HOXA5 and cancer: Beyond this, an emerging group of studies shows the dysregulation of HOXA5 in various solid/adult/pediatric/cancers or hematological malignancies and linked with higher pathological grade and poorer disease outcome (Chen et al., 2004; Wang et al., 2019).